Physician profile
Sharon D Malone
NPI 1902950280
$3,446.92
in general payments reported to CMS, 2019-2025
17 companies · $2,587 in 2025
The $2,587 reported for 2025 was more than what 91% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $628 · 2020: $232 · 2025: $2,587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,586.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $2,586.74 | 2025 | |
| Abbvie INC. | $167.61 | 2019-2020 | |
| Pfizer INC. | $121.61 | 2019-2020 | |
| Renovia INC | $106.95 | 2019 | |
| Therapeuticsmd, INC. | $65.68 | 2019-2020 | |
| Millicent US INC | $52.22 | 2019-2020 | |
| Astellas Pharma US INC | $49.69 | 2019 | |
| Coopersurgical, INC. | $48.46 | 2019-2020 | |
| Allergan, INC. | $40.79 | 2019-2020 | |
| Duchesnay USA Incorporated | $38.78 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.50 | 2019-2020 | |
| Amgen INC. | $34.31 | 2019 | |
| Vertical Pharmaceuticals, LLC | $29.78 | 2019 | |
| Avion Pharmaceuticals | $23.38 | 2019 | |
| Ferring Pharmaceuticals INC. | $20.55 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $12.42 | 2019 | |
| Olympus America INC. | $11.45 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Malone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.